Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04600882
Previous Study | Return to List | Next Study

Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04600882
Recruitment Status : Recruiting
First Posted : October 23, 2020
Last Update Posted : November 17, 2020
Sponsor:
Information provided by (Responsible Party):
Stalicla SA

Brief Summary:
This single-center, observational study is being conducted to identify a well-characterized subgroup within the ASD patient population, based on clinical symptoms and biosample analysis.

Condition or disease
Autism Spectrum Disorder

Layout table for study information
Study Type : Observational
Estimated Enrollment : 125 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder (ASD)
Estimated Study Start Date : November 30, 2020
Estimated Primary Completion Date : March 31, 2021
Estimated Study Completion Date : April 30, 2021

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Prevalence of non-behavioral phenotypical traits in sub-populations with Autism Spectrum Disorder (ASD) [ Time Frame: Day 0 ]
    A questionnaire will be administered to collect non-behavioral traits and co-occurring conditions data of the participants



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Nationwide Children's Hospital Primary Care Clinic
Criteria

Inclusion Criteria:

  • Previously diagnosed with ASD (based on DSM-5 criteria and supported by either ADI-R or ADOS-2 scores)
  • At least two well documented head circumference values recorded within the first 2 years of life
  • Participants must have a parent or reliable caregiver who agrees to provide information about the participant as required by the protocol and should be fluent in English

Exclusion Criteria:

  • Genetically identified ASD (syndromic form of autism, e.g. fragile X)
  • Episode of fever (i.e. ≥100.5 °F) or clinically significant illness without fever (as judged by the Investigator), within 10 days before the study visit

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04600882


Contacts
Layout table for location contacts
Contact: Aria Harter (614) 722-0723 aria.harter@nationwidechildrens.org

Locations
Layout table for location information
United States, Ohio
Nationwide Children's Hospital Recruiting
Columbus, Ohio, United States, 43205
Contact: Daniel Coury, MD, FAAP    614-722-2435    Daniel.Coury@nationwidechildrens.org   
Principal Investigator: Daniel Coury, MD, FAAP         
Sponsors and Collaborators
Stalicla SA
Layout table for additonal information
Responsible Party: Stalicla SA
ClinicalTrials.gov Identifier: NCT04600882    
Other Study ID Numbers: STP1-C002
First Posted: October 23, 2020    Key Record Dates
Last Update Posted: November 17, 2020
Last Verified: November 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Stalicla SA:
autism spectrum disorder
endophenotyping
observational
Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Pathologic Processes
Neurodevelopmental Disorders
Mental Disorders